By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


AVANIR Pharmaceuticals 

11388 Sorrento Valley Road

San Diego  California  92121  U.S.A.
Phone: 858-622-5200 Fax: 858-658-7447




Company News
AVANIR Pharmaceuticals (AVNR) Announces JAMA Publication Of Phase II Study Results Showing AVP-923 Significantly Reduced Agitation In Patients With Alzheimer's Disease 9/23/2015 11:07:18 AM
AVANIR Pharmaceuticals (AVNR) Prevails In NUEDEXTA Patent Appeal Maintaining Exclusivity Through 2026 8/11/2015 6:56:14 AM
AVANIR Pharmaceuticals (AVNR) Announces New Findings From Dementia/Alzheimer's Disease Cohort Of PRISM II Study At Alzheimer's Association International Conference 7/23/2015 8:54:20 AM
AVANIR Pharmaceuticals (AVNR) Announces Positive Top-Line Results From Stroke And TBI Cohorts Of PRISM II Study 6/30/2015 7:36:11 AM
AVANIR Pharmaceuticals (AVNR) Announces Publication Of Positive Phase IIIb Results From AVP-825 Head-To-Head COMPASS Study In The Journal "Headache" 6/17/2015 7:53:01 AM
AVANIR Pharmaceuticals (AVNR) Announces Presentation Of Survey Evaluating The Prevalence Of Pseudobulbar Affect (PBA) Symptoms In Retired Professional Football Players At The 12th Annual North American Brain Injury Society Conference 5/5/2015 10:34:52 AM
AVANIR Pharmaceuticals (AVNR) Announces Multiple Data Presentations Highlighting Its Central Nervous System (CNS) Therapeutics Franchise At The American Academy of Neurology 2015 Annual Meeting 4/15/2015 10:34:06 AM
AVANIR Pharmaceuticals (AVNR) Release: Through Laughter And Tears Comes First-Ever Documentary About Life With Pseudobulbar Affect (PBA) 12/9/2014 9:30:53 AM
AVANIR Pharmaceuticals (AVNR) Cancels Previously Scheduled Earnings Call 12/8/2014 7:28:00 AM
AVANIR Pharmaceuticals (AVNR) Announces Date Of Fiscal 2014 Fourth Quarter Financial Results And Conference Call 12/2/2014 11:48:10 AM